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Background: Many noninvasive arterial assessment techniques have been developed, measuring 
different parameters of arterial stiffness and endothelial function. However, there is little data 
available comparing different devices within the same subject. Therefore, the purpose of this 
study was to examine the repeatability and interrelationships between 3 different techniques to 
measure arterial stiffness and to compare this with forearm-mediated dilation.
Methods: Carotid-radial pulse wave velocity was measured by the Sphygmocor (SPWV) and 
Complior (CPWV) devices, cardio-ankle vascular index (CAVI) was measured by the VaSera 
device, vascular structure and function was assessed using ultrasonography and evaluated for 
reliability and compared in 20 apparently healthy, college-aged men and women. 
Results: The intraclass correlation coefﬁ  cient and standard error of the mean for the Sphygmocor 
(R = 0.56, SEM = 0.69), Complior (R = 0.62, SEM = 0.69), and VaSera (R = 0.60, SEM = 0.56), 
indicated moderate repeatability. Bland-Altman plots indicated a mean difference of 0.11 ± 0.84 
for SPWV, 0.13 ± 1.15 for CPWV, and –0.43 ± 0.90 for CAVI. No signiﬁ  cant interrelationships 
were found among the ultrasound measures and SPWV, CPWV, and CAVI. 
Conclusions: The three noninvasive modalities to study arterial stiffness reliably measures 
arterial stiffness however, they do not correlate with ultrasound measures of vascular function 
and structure in young and apparently healthy subjects. 
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During the last decade there has been a great interest in the detection of early vas-
cular disease in order to prevent further cardiovascular events. Consequently several 
techniques have been developed to estimate arterial stiffness (Cockcroft et al 1997; 
Wilkinson et al 1998), which has been a number of cardiovascular risk factors (Taquet 
et al 1993; Cockcroft et al 1997; Wilkinson et al 1998; Matsui et al 2004). Moreover, 
pulse wave velocity (PWV) has been shown to be a independent predictor for car-
diovascular morbidity and mortality in the general population and in patients with 
hypertension, type 2 diabetes, and end-stage renal disease (Nichols and O’Rourke 
1990; Cockcroft et al 1997; Laurent et al 2001, 2003; London and Cohn 2002; London 
et al 2003; Pannier et al 2005; Hansen et al 2006). This leads to the conclusion that 
that PWV is a useful tool in risk assessment for cardiovascular event and risk strati-
ﬁ  cation (Laurent et al 2006). 
PWV is calculated by measuring the pulse transit time and the distance traveled 
between two selected sites (ie, arterial distance over transit time), which is inversely 
related to the distensibility of the arterial walls. Currently, at least three devices, Sphyg-
mocor® 2000 (AtCor Medical, Sydney, Australia), Complior SP® (Artech Medical, 
Pantin, France), and VaSera® VS-1000 (Fukuda Denshi, Tokyo, Japan), are commonly 
used to assess arterial stiffness (Asmar et al 1995; Wilkinson et al 1998; Ngim et al Vascular Health and Risk Management 2007:3(3) 344
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1999; Rajzer et al 1999; Asmar et al 2001; Ravikumar et al 
2002; Mahmud and Feely 2003). The Sphygmocor® 2000 and 
Complior SP® measure PWV, while the VaSera® VS-1000 
measures the cardio-ankle vascular index (CAVI). CAVI is 
a pressure-independent index indicating the natural stiffness 
of the blood vessel and is based on the stiffness parameter 
β (Yambe et al 2004). Although several large studies dem-
onstrated that these noninvasive techniques may be valid 
instruments for determining vascular function, to date no 
study has compared these three devices in the same subject 
and no information is available regarding the comparison of 
these different parameters. 
Forearm-mediated vasodilation (FMD) is the noninva-
sive standard to determine endothelial function in subjects 
at risk for cardiovascular disease. However there are no 
comparative data available between the PWV techniques 
and FMD. Beyond the study of vascular function, early 
structural changes especially carotid intimal-media thick-
ness has been considered as a signiﬁ  cant predictor for CV 
morbidity and mortality (Chambless et al 2000; O’Leary and 
Polak 2002; Wattanakit et al 2005). Taking into account the 
sequential changes of the vasculature in the pathogenesis of 
hypertension and atherosclerosis, early detection of athero-
sclerotic disease should be focused on noninvasive detection 
of functional and morphological changes of the vasculature 
(Duprez et al 2000; Cohn et al 2005). There is only limited 
information available regarding the correlation between 
parameters providing information about functional changes 
and parameters regarding vascular structure.
The purpose of the present study was to determine: 1) the 
reliability of the three devices (Complior®, Sphygmocor®, 
VaSera®) in noninvasive assessment of arterial stiffness; 
2) the relationship of the arterial stiffness parameters among 
the three devices; and 3) the relationship among of the arte-
rial stiffness measures between three devices and established 
methods of assessing vascular structure, carotid intimal-
media thickness of the carotid artery (IMT), and endothelial 
function, percent dilation of the brachial artery through ﬂ  ow 
mediated dilation (FMD), and endothelium-independent 
dilation (EID).
Methods
Subjects
Twenty healthy volunteers, 10 men and 10 women, aged 
18–35 years (mean age, 25 ± 3.5 years) participated in this 
study. Participants were recruited from the university cam-
pus by advertisement. The study protocol was approved by 
the local medical ethical committee. All participants were 
nonsmokers, free of cardiovascular disease, and not using 
prescription medications as determined by a medical history 
questionnaire. 
Study protocol 
To avoid diurnal variations all testing was conducted at a 
similar time, between 6:00 a.m. and 10:00 a.m. on three 
separate assessment days. Participants arrived after an 
overnight fast and were asked to refrain from using caffeine 
the morning of each assessment day, but otherwise maintain 
their usual lifestyle between assessment days. Women of 
reproductive age were scheduled for assessments within 
three days after the completion of a cycle of menstruation. 
All testing procedures took place in a temperature controlled 
(22 °C) quiet room.
During assessment day one, height and weight were 
obtained using a wall-mounted stadiometer (Seca, Hamburg, 
Germany) and a digital scale (Tanita BWB-800, Tanita Corp., 
Tokyo, Japan). Participants were examined in a supine posi-
tion during all procedures. Following 10 minutes of supine 
rest, left brachial blood pressure was measured by ausculta-
tion. The distance between the supra-sternal notch and the 
radial artery, and supra-sternal notch and the carotid artery 
were obtained. This distance obtained was used for all three 
devices and used throughout the remainder of the study to 
limit any potential variation. This procedure was followed 
during each assessment day to minimize variation.  
Carotid-radial pulse wave velocity was assessed by the 
Sphygmocor® 2000, the Complior SP®, and the cardiac-
ankle index was obtained by the VaSera® VS-1000 during 
each of the three separate assessment days. The order of 
each modality was randomized for each assessment day. The 
same investigator assessed the PWV using all devices and 
during all three assessments days to limit potential variation 
between testers. Carotid IMT, FMD, and EID were assessed 
following the PWV measures during day one of testing. 
Study procedures
Sphygmocor 2000 (Atcor, Sydney, Australia), Software Ver-
sion 7.01, utilizes a small pencil sized tonometer (pressure 
transducer) that was placed on the skin over the carotid and 
radial arteries. The radial and carotid pulses were located by 
palpation with the optimal position selected as the position 
that yielded the best quality signal output. The tonometer 
was placed at an angle that was perpendicular or directly 
above the artery with the appropriate pressure applied. The 
Sphygmocor PWV was determined by using the intersecting Vascular Health and Risk Management 2007:3(3) 345
Measurement of arterial stiffness 
tangent algorithm to identify the foot of the waveform using 
gating to the R-wave of the electrocardiogram (ECG) for the 
2 sites. The tonometer was placed at the same point of the 
arteries during all testing.
Complior SP (Atech Medical, Pantin, France), Software 
Version V1.1+, utilizes circular pulse wave sensors that 
were placed on the skin over both the carotid and radial 
arteries. The arteries were palpated to ﬁ  nd the location of 
the points with the most pronounced pulse pressure waves. 
The pulse sensors were adjusted until the clearest signal was 
obtained. The Complior PWV was determined by focusing 
on the foot of the maximal systolic rise as the pulse transit 
time for continuous pressure-wave signals. The transducers 
were placed at the same location over the arteries during all 
testing procedures. 
VaSera VS-1000 (Fukuda Denshi, Tokyo, Japan), 
Software Version 08-01, utilizes blood pressure cuffs with 
sensors for all four limbs to generate plethysmograms. The 
cuffs were placed on the upper arms, the right knee, and both 
ankles, ECG leads were placed on the wrists, and a phonocar-
diogram (PCG) was placed at the right sternal border in the 
2nd intercostal space. All limbs were resting on limb cushions 
to avoid limb contact on the bed and to minimize potential 
variation. The VaSera Cardiac-Ankle Index is determined by 
using the EGC, PCG, and the waveform of the brachial and 
ankle arteries as a continuous measure based on the stiffness 
parameter β (Yambe et al 2004). 
Endothelial function was measured via noninvasive 
ultrasound imaging. Participants were asked to lie supine 
for a 10-minute resting period where a three-lead ECG was 
placed for monitoring of heart rate and rhythm throughout 
the procedures. Standard ultrasonography equipment (Image 
Point HX, Philips Medical, Bothwell, WA) with a 7.5-MHz 
linear array probe was used to obtain B-mode images of 
the left brachial artery approximately 2–10 cm proximal 
to the elbow. The transducer was held at a ﬁ  xed point over 
the imaged artery at a constant distance from the skin by a 
stereostactic arm. Following measurement of resting artery 
diameter, a blood pressure cuff was placed distally to the 
brachial artery (antecubital space) and inﬂ  ated to a suprasys-
tolic level (200 mm/Hg) for 5 minutes to induce ischemia. 
After abrupt release of the cuff pressure, changes in blood 
ﬂ  ow and vessel diameter (FMD) over a 5-minute period were 
imaged (Celermajer 1998). The images were captured and 
triggered off the R wave of the electrocardiogram and then 
digitalized and stored on a personal computer for later analy-
sis (CVI, Information Integrity, Boston, MA). FMD peak, 
time to peak, and area under the curve were calculated in a 
statistical program (GraphPad Prism version 4.0, GraphPad 
Software, Inc, San Diego, CA). The reproducibility for the 
FMD technique in our lab has shown a mean difference of 
0.53% ± 0.28% for analyses (Kelly et al 2004). Vascular 
smooth muscle function was examined by EID by sublingual 
nitroglycerin (0.4 mg) administration. The brachial artery 
diameter was measured for 5 minutes following nitroglyc-
erin administration using the ultrasound system as described 
above. Carotid IMT was measured by placing the ultrasound 
transducer distally to the carotid artery; images were obtained 
and analyzed for IMT (CVI, Information Integrity, Boston, 
MA) (Celermajer 1998).
Data analysis
All data was tested for normality. Means and standard 
deviations were calculated for all descriptive variables. 
Intra-class correlation coefficients (R) and standard errors 
of measurement (SEM) were calculated for each instru-
ment in order to examine the reliability of each device. 
Bland-Altman plots from the first and second measure-
ment were utilized to further assess the repeatability of 
each device (Bland and Altman 1986). Separate Pearson’s 
simple correlation coefficients were calculated to assess 
the relationship of the different parameters obtained with 
the Sphygmocor®, Complior®, and VaSera® devices. Sepa-
rate Pearson Product Moment correlation coefﬁ  cients were 
also calculated to assess the relationship among carotid 
IMT, EID, FMD derived parameters and the vascular 
measures of the Sphygmocor®, VaSera®, and Complior® 
devices. Statistical analyses were performed using Sta-
tistical Package for the Social Sciences version 12.0 for 
Windows (SPSS, Inc, Chicago, IL). The level of statistical 
significance was set at P < 0.05 for all analyses.
Results
The subjects’ characteristics are presented in Table 1. The 
PWV values from the Complior® and Sphygmocor® were 
reasonable consistent across the three assessments and re-
sulted in moderately acceptable intraclass correlations and 
low standard errors of estimate. The CAVI values from the 
VaSera® device resulted in similar results (Table 2). The 
interpretation of the Bland and Altman plots of the ﬁ  rst two 
measurements supported the statistical results of the intra-
class correlation analysis and standard errors of estimate 
scores for the Sphygmocor® (Figure 1A), the Complior® 
(Figure 1B), and the VaSera® (Figure 1C). The repeatability 
was acceptable for all three devices with only the CAVI 
scores resulting in a slight negative bias for the second Vascular Health and Risk Management 2007:3(3) 346
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assessment. The CAVI scores were also slightly more vari-
able with two different scores falling outside of two standard 
deviations (Figure 1C). 
The intra-class correlation coefﬁ  cients for each of the 
arterial stiffness assessment devices including the Com-
plior SP, the Sphymocor 2000, and the VaSera VS-1000 
(Table 2), were all signiﬁ  cant (R = 0.56–0.62, P < 0.001). 
The three arterial stiffness assessment devices had similar 
SEM: 0.56–0.69. These initial ﬁ  ndings may suggest that 
similar results may be found with use of these instruments 
in intervention studies.  
Mean EID, FMD, and carotid IMT values are presented 
in Table 3. The Pearson Product Moment Correlation for the 
relationships among the vascular scores of the devices indi-
cated no signiﬁ  cant correlations between the PWV devices 
or between the established ultrasound measures of vascular 
structure and function, and the vascular scores of the three 
PWV devices (Table 4). 
Discussion
The purpose of this study was to determine the reliability, 
and interrelationships of three devices (Sphygmocor® 2000, 
Complior SP®, and VaSera® VS-1000) commonly used in 
noninvasive determination of arterial stiffness. In addition, 
these devices were compared to established ultrasound 
techniques used to measure vascular function and structure. 
Although all three devices appeared to be reliable, they did 
not signiﬁ  cantly correlate with each other or with the methods 
of measuring EID, FMD, and carotid IMT.
Similar to previous reports (Wilkinson et al 1998; 
Avest et al 2005), the Bland-Altman plots of PWV for 
the Sphygmocor® and Complior SP® devices indicate that 
as PWV values increase, the variation may also increase, 
however only one value was greater than two standard 
deviations indicating that the repeatability is acceptable. The 
Bland-Altman Plots from the CAVI values of the VaSera® 
VS-1000 indicated a slight negative bias for the second 
group of assessments (mean difference -0.43 ± 0.88). More 
research in a less healthy group may be needed to assess the 
repeatability of the devices in a population more likely to be 
screened for cardiovascular diseases. 
There were no signiﬁ  cant correlations found between 
the three devices used to asses PWV in this study. It may be 
expected that the Complior SP® PWV and the Sphygmocor® 
2000 PWV would correlate since the distance, and palpation 
sites used for both devices were identical, as well as utilizing 
similar methodology in the acquisition of PWV. The lack 
of a signiﬁ  cant association between these devices may be 
explained by variation in sensor technology and software, 
as well as differences in the population-based conversion 
formulas. The use of simultaneously obtained radial and 
carotid arteries waveforms by the Complior SP® may have 
contributed to the slightly larger intra-class correlation coef-
ﬁ  cient by eliminating minor variations occurring as a result 
from sequential ECG gated measures. The Sphygmocor® 
2000 device utilizes a handheld arterial tonometer that 
records pressure waveforms and measures propagation time 
using the foot-to-foot method with sequential recordings 
referenced to the R wave of the ECG. The Complior SP® 
device records radial and carotid waveforms simultaneously 
using mechanotransducers, and timing is referenced to the 
point of maximum systolic upstroke (Millasseau et al 2005). 
The CAVI utilizes a different methodology by creating 
plethysmograms produced by applying an ECG, PCG, and 
blood pressure cuff sensors for the brachial, posterior tibial, 
and popletial arteries. The placement of the blood pressure 
cuff sensors may have introduced variance in calculation of 
the CAVI as the average blood pressure readings are used. 
Table 2 Intraclass reliability coefﬁ  cients and standard errors of measurement for pulse wave velocity, and cardio-ankle vascular index, 
across three measurements
Device  Visit 1  Visit 2  Visit 3  R  P =  SEM
PWVsphyg (m/s)  7.66 ± 0.88  7.77 ± 1.01  7.79 ± 1.21  .56  < 0.001  0.69
PWVcompl (m/s)  9.46 ± 0.98  9.69 ± 1.38  9.36 ± 0.99  .62  < 0.001  0.69
CAVI  6.45 ± 1.11  6.02 ± 0.75  6.21 ± 0.82  .60  < 0.001  0.56
Note: Values presented as mean PWV in meters/second ± SD.
Abbreviations: CAVI, cardio-ankle vascular index; PWVsphyg, Sphygmocor pulse wave velocity, PWVcompl, Complior pulse wave velocity; R, intraclass correlation coefﬁ  cient; 
SEM, standard error of measurement. 
Table 1 Subjects’ characteristics
 Men  Women
N = 20  10  10
Age (yrs)  26.1 ± 3.0  23.3 ± 4.0
Height (cm)  180.7 ± 5.3  164.1 ± 4.7
Weight (kg)  82.5 ± 8.9  58.4 ± 6.3
BMI (kg/m2)  25.1 ± 1.9  21.6 ± 1.7
Note: All the data in Table 1 are expressed as mean ± SD.
Abbreviations: BMI, body mass index; SD, standard deviation. Vascular Health and Risk Management 2007:3(3) 347
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It is possible that the placement of the various sensor intro-
duced more variance resulting in the 2 scores outside of 2 
standard deviations illustrated in the Bland-Altman plots. 
Furthermore, the CAVI measurement is based on the distance 
and time from the heart valve, brachial, popletial, and ankle 
pulses to calculate the stiffness index β. This could have 
contributed to the nonsigniﬁ  cant ﬁ  nding of interrelationship 
between the devices. 
Millasseau and colleagues (2005) compared carotid-femo-
ral PWV measures from the Sphygmocor® to the Complior® 
device and found a substantial difference between resting 
values, which was attributed to a systematic difference in 
transit time. The authors further determined that the compu-
tation of PWV is mainly dependent on the algorithm used 
to determine transit time and that the contribution of other 
sources of variation is relatively minor. Therefore, the lack 
of interrelation between these devices may also be due to the 
use of different timing algorithms. Other potential inﬂ  uences 
that may have affected the relationship between the different 
devices include sympathetic activation with changes in heart 
rate and blood pressure (Boutouyrie et al 1994; Oliver and 
Webb 2003). Although the same blood pressure reading was 
used for both the Sphygmocor® and the Complior®, it is pos-
sible that the blood pressure changed during the assessment 
session. The blood pressure used for the CAVI measurement 
was determined by the device, and deﬁ  ned as the average blood 
pressure obtained from the left and right brachial arteries, this 
may also have contributed to the lack of signiﬁ  cant ﬁ  ndings 
of interrelationship between the devices. Since pulse pres-
sure ampliﬁ  cation may differ between individuals, using the 
peripheral blood pressure obtained at brachial artery may have 
introduced a source of bias of assessment as well (Davies and 
Struthers 2003). Change in heart rate between assessments 
may also have introduced variation between the devices, it 
was not possible to control for changes in heart rate or blood 
pressure in this study. 
It will be of clinical importance to develop different 
PWV assessment tools that use similar timing algorithms in 
order to make PWV a more universal tool for assessment of 
vascular function. Furthermore, the values for these indices 
differ greatly, which will make it very difﬁ  cult to establish 
reference values, and risk stratiﬁ  cation by age and gender 
for PWV and/or other measures of vascular function. The 
lack of signiﬁ  cant relationship between the 3 devices sug-
gests that they cannot be used interchangeably and studies 
using different systems may not be comparable across the 
literature. These results indicates that caution should be used 
when estimating cardiovascular risk during clinical trials 
while drawing inferences from the results obtained using 
these 3 different devices. 
Table 3 Mean brachial FMD and carotid IMT values
Measure Mean  SD
Baseline diameter (mm)  3.7  .66
IMT (mm)  0.27  .11
EID PD (percent)  24.2  8.0
EID TTP (seconds)  278.0  28.1
EID AUC  3325.5  1417.7
FMD PD (percent)  4.9  2.7
FMD TTP (seconds)  65.0  28.2
FMD AUC  562.6  359.7
Abbreviations: AUC, area under the curve; Baseline diameter, resting brachial 
artery diameter; EID, endothelial-independent dilation; FMD, ﬂ  ow-mediated dilation; 
IMT, intima-media thickness; PD, peak dilation; TTP, time to peak. 
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Figure 1 Bland-Altman plot showing the intra-observer differences against the 
mean Pulse wave velocity value of Sphygomocor (Panel A), Complior (Panel B), and 
Cardiac-ankle index VaSera (Panel C). Dotted line represents two standard devia-
tions from the mean value.Vascular Health and Risk Management 2007:3(3) 348
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There were no signiﬁ  cant correlations found between 
PWV and the ultrasound measures of arterial structure (ca-
rotid IMT) and function (FMD) in this study. The correlation 
coefﬁ  cients for several of these comparisons were small and 
had nonsigniﬁ  cant P-values. This ﬁ  nding is in agreement 
with Liang and colleagues (1998) who reported no signiﬁ  cant 
associations between brachial FMD and PWV. The author did 
report a signiﬁ  cant association between IMT and PWV in an 
older healthy study population. In contrast, Wilson and col-
leagues (2004) found a signiﬁ  cant association between PWV 
and brachial FMD in healthy young participants, but failed 
to ﬁ  nd a signiﬁ  cant association between PWV and brachial 
FMD in older participants with diagnosed type 2 diabetes 
as well as between IMT and PWV in either population, 
which is in agreement with the results of the present study. 
Contrary to these ﬁ  ndings, Kobayashi and colleagues (2004) 
reported a signiﬁ  cant association between PWV and brachial 
FMD as well as between IMT and PWV in participants with 
risk factors for cardiovascular disease (including type 2 
diabetes) and diagnosed atherosclerosis. Interestingly, both 
Wilson and colleagues (1998) and Kobayahsi and colleagues 
(2004) suggested that combining these measures of arterial 
function and structure might increase predictive accuracy of 
cardiovascular risk. 
It is apparent that there is a large amount of variation 
between measurements, with studies reporting conﬂ  icting 
results, suggesting that relationships may vary signiﬁ  cantly 
between individuals, between studies, and between devices 
utilized to measure PWV. It is therefore possible that the lack 
of relationship between PWV, brachial FMD, and IMT found 
in the present study is due to the use of a relatively young and 
healthy study population. Moreover, the different devices used 
for obtaining PWV may further explain the lack of association 
found between PWV, carotid IMT, and brachial FMD. It is 
possible that a more diverse (and less healthy) sample may be 
needed to identify signiﬁ  cant correlations between the vascular 
scores of the devices and established ultrasound measures of 
vascular structure and function. Moreover, PWV, FMD, and 
IMT evaluate different aspects of arterial health and athero-
sclerotic progress, and target different sites of the artery, which 
may help explain the lack of association between them. PWV 
measures arterial stiffening, which is most likely the result of 
functional changes within the vascular tree. FMD measures 
vasodilation and IMT measures medial hypertrophy, which 
are different segments of the arterial wall (Boutouyire et al 
1999; Kobayashi et al 2004). 
The lack of interrelation between these devices may have 
pivotal implications in clinical intervention studies and ﬁ  nal 
interpretation of data. Physicians and researchers should not 
use the devices investigated in this study interchangeably and 
caution should be used when making any inferences between 
studies utilizing these different devices in a relatively young 
and healthy population. In conclusion, the three noninvasive 
modalities investigated in this study may reliably measure 
PWV and indirectly arterial stiffness, but they fail to be 
consistent and in good agreement with each other and with 
ultrasound measures of endothelial function, and arterial 
morphology in this young and healthy population sample. A 
larger sample size with a greater range in cardiovascular risk 
will be needed in the future to verify these ﬁ  ndings utilizing 
the assessment tools employed in this study.
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